申请人:Mecox Curemed Co., Ltd.
公开号:EP3698805A1
公开(公告)日:2020-08-26
The present invention relates to a composition for pain, containing a fraction obtained by solvent fractionation of a Zanthoxylum piperitum leaf extract. More specifically, a solvent fraction isolated from Zanthoxylum piperitum leaves suppresses all of pain, inflammation and arthritis in a pain-induced animal model, an inflammation-induced model and an arthritis-induced model and, with respect to molecular markers related thereto, exhibits very excellent expression and suppression patterns, thereby being usable in a pharmaceutical composition that is very effective in the treatment of pain- and inflammation-based arthritis.
本发明涉及一种治疗疼痛的组合物,其中含有一种通过对 Zanthoxylum piperitum 叶提取物进行溶剂分馏获得的馏分。更具体地说,从Zanthoxylum piperitum叶中分离出的溶剂馏分可抑制疼痛诱导动物模型、炎症诱导模型和关节炎诱导模型中的所有疼痛、炎症和关节炎,并且在与之相关的分子标志物方面,表现出非常出色的表达和抑制模式,从而可用于药物组合物,对治疗疼痛和炎症性关节炎非常有效。